Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

(2016) Sam S. Chang et al.   JOURNAL OF UROLOGY

Update on the management of non-muscle invasive bladder cancer

(2016) Saad Aldousari et al.   CUAJ-Canadian Urological Association Journal

Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients

(2015) William Martin-Doyle et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Outcome of Patients with T1 Micropapillary Urothelial Carcinoma of the Bladder

(2014) Massimiliano Spaliviero et al.   JOURNAL OF UROLOGY

Sexual dysfunction after cystectomy and urinary diversion

(2014) Rishi A. Modh et al.   Nature Reviews Urology

Determining the Role of Cystectomy for High-grade T1 Urothelial Carcinoma

(2013) Siamak Daneshmand   UROLOGIC CLINICS OF NORTH AMERICA

Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?

(2012) Gina M. Badalato et al.   BJU INTERNATIONAL

Early vs delayed radical cystectomy for ‘high-risk’ carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival

(2011) Wolfgang Jäger et al.   BJU INTERNATIONAL

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review

(2011) Sven van den Bosch et al.   EUROPEAN UROLOGY

T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy

(2011) E. De Berardinis et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer

(2010) Wolfgang Otto et al.   BJU INTERNATIONAL

Long-term Efficacy of Maintenance Bacillus Calmette-Guérin versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent TaT1 Tumours without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study with a 20-Year Follow-up

(2009) Riikka Järvinen et al.   EUROPEAN UROLOGY

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study

(2009) Miloš Duchek et al.   EUROPEAN UROLOGY

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

(2009) Richard J. Sylvester et al.   EUROPEAN UROLOGY

The Pathologist’s Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer Grading

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications

(2009) Matthias May et al.   EUROPEAN UROLOGY

An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer

(2009) Girish S. Kulkarni et al.   EUROPEAN UROLOGY

Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)

(2009) Richard E. Hautmann et al.   WORLD JOURNAL OF UROLOGY

Organ erhaltende Therapie oder initiale Zystektomie beim T1G3-Harnblasenkarzinom: Welche Faktoren helfen bei der Therapieentscheidung?

(2008) S. Denzinger et al.   AKTUELLE UROLOGIE

Invasive T1 bladder cancer: indications and rationale for radical cystectomy

(2008) John P. Stein et al.   BJU INTERNATIONAL

Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

(2008) Ahmad Shabsigh et al.   EUROPEAN UROLOGY

History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story

(2007) Harry W. Herr et al.   JOURNAL OF UROLOGY